MAPT and Alzheimer disease: Similarly, the levels of Aβ1–42, total Tau and phosphorylated Tau at S181 (p-S181-Tau) or S396 (p-S396-Tau) in exosomes could differentiate patients with AD from those with MCI and/or controls [137,138].